s29.1	"early use improve outcomes"
s29.1	"early use improve outcomes"	rdf:subject	"early use"
s29.1	"early use"	rdfs:subClassOf	"use"
s29.1	"early use"	rdfs:member	"early"
s29.1	"early use improve outcomes"	rdf:predicate	"improve"
s29.1	"early use improve outcomes"	rdf:object	"outcome"
s29	"early use appears to improve outcomes"
s29	"early use appears to improve outcomes"	rdf:subject	"early use"
s29	"early use"	rdfs:subClassOf	"use"
s29	"early use"	rdfs:member	"early"
s29	"early use appears to improve outcomes"	rdf:predicate	"appear"
s27.2	"cortisone sparing in antibodypositive"
s27.2	"cortisone sparing in antibodypositive"	rdf:subject	"cortisone"
s27.2	"cortisone sparing in antibodypositive"	rdf:predicate	"spar"
s27.2	"cortisone sparing in antibodypositive"	local:AM-LOC	"antibodypositive"
s27.1	"early use facilitate cortisone sparing in antibodypositive"
s27.1	"early use facilitate cortisone sparing in antibodypositive"	rdf:subject	"early use"
s27.1	"early use"	rdfs:subClassOf	"use"
s27.1	"early use"	rdfs:member	"early"
s27.1	"early use facilitate cortisone sparing in antibodypositive"	rdf:predicate	"facilitate"
s27.1	"early use facilitate cortisone sparing in antibodypositive"	rdf:object	"cortisone spar in antibodypositive"
s27.1	"cortisone spar"	rdfs:subClassOf	"spar"
s27.1	"cortisone spar"	rdfs:member	"cortisone"
s27.1	"cortisone spar in antibodypositive"	rdfs:member	"cortisone spar"
s27.1	"cortisone spar in antibodypositive"	rdfs:member	"antibodypositive"
s27	"early use appears to facilitate cortisone sparing in antibodypositive"
s27	"early use appears to facilitate cortisone sparing in antibodypositive"	rdf:subject	"early use"
s27	"early use"	rdfs:subClassOf	"use"
s27	"early use"	rdfs:member	"early"
s27	"early use appears to facilitate cortisone sparing in antibodypositive"	rdf:predicate	"appear"
s26	"this study suggests good tolerability and efficacy of rituximab in juvenile myasthenia gravis"
s26	"this study suggests good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdf:subject	"study"
s26	"this study suggests good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdf:predicate	"suggest"
s26	"this study suggests good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdf:object	"good tolerability and efficacy of rituximab in juvenile myasthenia gravis"
s26	"good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdfs:member	"juvenile myasthenia gravis"
s26	"good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdfs:member	"rituximab"
s26	"good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdfs:member	"efficacy"
s26	"good tolerability and efficacy of rituximab in juvenile myasthenia gravis"	rdfs:member	"good tolerability"
s26	"myasthenia gravis"	rdfs:member	"myasthenia"
s26	"juvenile myasthenia"	rdfs:subClassOf	"myasthenia"
s26	"good tolerability"	rdfs:subClassOf	"tolerability"
s26	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s26	"juvenile myasthenia gravis"	rdfs:member	"juvenile myasthenia"
s26	"juvenile myasthenia"	rdfs:member	"juvenile"
s26	"good tolerability"	rdfs:member	"good"
s26	"juvenile myasthenia gravis"	rdfs:subClassOf	"gravis"
s26	"good tolerability of rituximab"	rdfs:member	"good tolerability"
s26	"good tolerability of rituximab"	rdfs:member	"rituximab"
s26	"good tolerability of rituximab in juvenile myasthenia"	rdfs:member	"good tolerability of rituximab"
s26	"good tolerability of rituximab in juvenile myasthenia"	rdfs:member	"juvenile myasthenia"
s25	"the use of rituximab as a firstline immunosuppressant increased in france over the last 10 years as a firstline immunosuppressant"
s25	"the use of rituximab as a firstline immunosuppressant increased in france over the last 10 years as a firstline immunosuppressant"	rdf:subject	"use of rituximab a a firstline immunosuppressant"
s25	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"use"
s25	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"rituximab"
s25	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"firstline immunosuppressant"
s25	"firstline immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s25	"firstline immunosuppressant"	rdfs:member	"firstline"
s25	"use of rituximab"	rdfs:member	"use"
s25	"use of rituximab"	rdfs:member	"rituximab"
s25	"the use of rituximab as a firstline immunosuppressant increased in france over the last 10 years as a firstline immunosuppressant"	rdf:predicate	"increase"
s25	"the use of rituximab as a firstline immunosuppressant increased in france over the last 10 years as a firstline immunosuppressant"	local:AM-LOC	"france"
s25	"the use of rituximab as a firstline immunosuppressant increased in france over the last 10 years as a firstline immunosuppressant"	local:AM-TMP	"last 10 year a a firstline immunosuppressant"
s25	"last 10 year a a firstline immunosuppressant"	rdfs:member	"year"
s25	"last 10 year a a firstline immunosuppressant"	rdfs:member	"firstline immunosuppressant"
s25	"firstline immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s25	"firstline immunosuppressant"	rdfs:member	"firstline"
s25	"10 year"	rdfs:subClassOf	"year"
s25	"last 10 year"	rdfs:subClassOf	"10 year"
s24	"rituximab well tolerated"
s24	"rituximab well tolerated"	rdf:subject	"rituximab"
s24	"rituximab well tolerated"	rdf:predicate	"tolerate"
s24	"rituximab well tolerated"	local:AM-MNR	"well"
s23.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"
s23.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:subject	"cortisone"
s23.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:predicate	"spar"
s23.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:object	"compare with rituximab treatment a thirdline immunosuppression"
s23.1	"compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"compare"
s23.1	"compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"rituximab treatment"
s23.1	"compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"thirdline immunosuppression"
s23.1	"thirdline immunosuppression"	rdfs:member	"thirdline"
s23.1	"rituximab treatment"	rdfs:member	"rituximab"
s23.1	"thirdline immunosuppression"	rdfs:subClassOf	"immunosuppression"
s23.1	"rituximab treatment"	rdfs:subClassOf	"treatment"
s23.1	"compare with rituximab treatment"	rdfs:member	"compare"
s23.1	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s23	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"
s23	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:subject	"use of rituximab a a firstline immunosuppressant"
s23	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"use"
s23	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"rituximab"
s23	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"firstline immunosuppressant"
s23	"firstline immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s23	"firstline immunosuppressant"	rdfs:member	"firstline"
s23	"use of rituximab"	rdfs:member	"use"
s23	"use of rituximab"	rdfs:member	"rituximab"
s23	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:predicate	"show"
s23	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:object	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"percent"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"thirdline immunosuppression"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"rituximab treatment"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"cortisone spar compare"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"better efficacy"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"result"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"discontinuation"
s23	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"immunosuppressant"
s23	"cortisone spar"	rdfs:subClassOf	"spar"
s23	"spar compare"	rdfs:subClassOf	"compare"
s23	"rituximab treatment"	rdfs:member	"rituximab"
s23	"rituximab treatment"	rdfs:subClassOf	"treatment"
s23	"thirdline immunosuppression"	rdfs:member	"thirdline"
s23	"thirdline immunosuppression"	rdfs:subClassOf	"immunosuppression"
s23	"cortisone spar compare"	rdfs:member	"cortisone spar"
s23	"better efficacy"	rdfs:subClassOf	"efficacy"
s23	"better efficacy"	rdfs:member	"better"
s23	"spar compare"	rdfs:member	"spar"
s23	"cortisone spar"	rdfs:member	"cortisone"
s23	"cortisone spar compare"	rdfs:subClassOf	"compare"
s23	"75 percent"	rdfs:subClassOf	"percent"
s23	"better efficacy with discontinuation"	rdfs:member	"better efficacy"
s23	"better efficacy with discontinuation"	rdfs:member	"discontinuation"
s23	"discontinuation of immunosuppressant"	rdfs:member	"discontinuation"
s23	"discontinuation of immunosuppressant"	rdfs:member	"immunosuppressant"
s23	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"discontinuation of immunosuppressant"
s23	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"75 percent"
s23	"75 percent of result"	rdfs:member	"75 percent"
s23	"75 percent of result"	rdfs:member	"result"
s23	"result in cortisone spar"	rdfs:member	"result"
s23	"result in cortisone spar"	rdfs:member	"cortisone spar"
s23	"compare with rituximab treatment"	rdfs:member	"compare"
s23	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s22.1	"cortisone sparing compared with rituximab treatment as a secondline"
s22.1	"cortisone sparing compared with rituximab treatment as a secondline"	rdf:subject	"cortisone"
s22.1	"cortisone sparing compared with rituximab treatment as a secondline"	rdf:predicate	"spar"
s22.1	"cortisone sparing compared with rituximab treatment as a secondline"	local:AM-ADV	"compare with rituximab treatment a a secondline"
s22.1	"compare with rituximab treatment a a secondline"	rdfs:member	"secondline"
s22.1	"compare with rituximab treatment a a secondline"	rdfs:member	"compare"
s22.1	"compare with rituximab treatment a a secondline"	rdfs:member	"rituximab treatment"
s22.1	"rituximab treatment"	rdfs:member	"rituximab"
s22.1	"rituximab treatment"	rdfs:subClassOf	"treatment"
s22.1	"compare with rituximab treatment"	rdfs:member	"compare"
s22.1	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s22	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as a secondline"
s22	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as a secondline"	rdf:subject	"use of rituximab a a firstline immunosuppressant"
s22	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"use"
s22	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"rituximab"
s22	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"firstline immunosuppressant"
s22	"firstline immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s22	"firstline immunosuppressant"	rdfs:member	"firstline"
s22	"use of rituximab"	rdfs:member	"use"
s22	"use of rituximab"	rdfs:member	"rituximab"
s22	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as a secondline"	rdf:predicate	"show"
s22	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as a secondline"	rdf:object	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"secondline"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"percent"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"rituximab treatment"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"patient"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"cortisone spar compare"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"better efficacy"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"discontinuation"
s22	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"immunosuppressant"
s22	"cortisone spar"	rdfs:subClassOf	"spar"
s22	"spar compare"	rdfs:subClassOf	"compare"
s22	"rituximab treatment"	rdfs:member	"rituximab"
s22	"rituximab treatment"	rdfs:subClassOf	"treatment"
s22	"cortisone spar compare"	rdfs:member	"cortisone spar"
s22	"better efficacy"	rdfs:subClassOf	"efficacy"
s22	"better efficacy"	rdfs:member	"better"
s22	"spar compare"	rdfs:member	"spar"
s22	"cortisone spar"	rdfs:member	"cortisone"
s22	"cortisone spar compare"	rdfs:subClassOf	"compare"
s22	"75 percent"	rdfs:subClassOf	"percent"
s22	"better efficacy with discontinuation"	rdfs:member	"better efficacy"
s22	"better efficacy with discontinuation"	rdfs:member	"discontinuation"
s22	"discontinuation of immunosuppressant"	rdfs:member	"discontinuation"
s22	"discontinuation of immunosuppressant"	rdfs:member	"immunosuppressant"
s22	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"discontinuation of immunosuppressant"
s22	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"75 percent"
s22	"75 percent of patient"	rdfs:member	"75 percent"
s22	"75 percent of patient"	rdfs:member	"patient"
s22	"patient in cortisone spar"	rdfs:member	"patient"
s22	"patient in cortisone spar"	rdfs:member	"cortisone spar"
s22	"compare with rituximab treatment"	rdfs:member	"compare"
s22	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s21.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"
s21.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:subject	"cortisone"
s21.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:predicate	"spar"
s21.1	"cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:object	"compare with rituximab treatment a thirdline immunosuppression"
s21.1	"compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"compare"
s21.1	"compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"rituximab treatment"
s21.1	"compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"thirdline immunosuppression"
s21.1	"thirdline immunosuppression"	rdfs:member	"thirdline"
s21.1	"rituximab treatment"	rdfs:member	"rituximab"
s21.1	"thirdline immunosuppression"	rdfs:subClassOf	"immunosuppression"
s21.1	"rituximab treatment"	rdfs:subClassOf	"treatment"
s21.1	"compare with rituximab treatment"	rdfs:member	"compare"
s21.1	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s21	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"
s21	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:subject	"use of rituximab a a firstline immunosuppressant"
s21	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"use"
s21	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"rituximab"
s21	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"firstline immunosuppressant"
s21	"firstline immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s21	"firstline immunosuppressant"	rdfs:member	"firstline"
s21	"use of rituximab"	rdfs:member	"use"
s21	"use of rituximab"	rdfs:member	"rituximab"
s21	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:predicate	"show"
s21	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of patients in cortisone sparing compared with rituximab treatment as thirdline immunosuppression"	rdf:object	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"percent"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"thirdline immunosuppression"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"rituximab treatment"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"patient"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"cortisone spar compare"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"better efficacy"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"discontinuation"
s21	"better efficacy with a discontinuation of immunosuppressant in 75 percent of patient in cortisone spar compare with rituximab treatment a thirdline immunosuppression"	rdfs:member	"immunosuppressant"
s21	"cortisone spar"	rdfs:subClassOf	"spar"
s21	"spar compare"	rdfs:subClassOf	"compare"
s21	"rituximab treatment"	rdfs:member	"rituximab"
s21	"rituximab treatment"	rdfs:subClassOf	"treatment"
s21	"thirdline immunosuppression"	rdfs:member	"thirdline"
s21	"thirdline immunosuppression"	rdfs:subClassOf	"immunosuppression"
s21	"cortisone spar compare"	rdfs:member	"cortisone spar"
s21	"better efficacy"	rdfs:subClassOf	"efficacy"
s21	"better efficacy"	rdfs:member	"better"
s21	"spar compare"	rdfs:member	"spar"
s21	"cortisone spar"	rdfs:member	"cortisone"
s21	"cortisone spar compare"	rdfs:subClassOf	"compare"
s21	"75 percent"	rdfs:subClassOf	"percent"
s21	"better efficacy with discontinuation"	rdfs:member	"better efficacy"
s21	"better efficacy with discontinuation"	rdfs:member	"discontinuation"
s21	"discontinuation of immunosuppressant"	rdfs:member	"discontinuation"
s21	"discontinuation of immunosuppressant"	rdfs:member	"immunosuppressant"
s21	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"discontinuation of immunosuppressant"
s21	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"75 percent"
s21	"75 percent of patient"	rdfs:member	"75 percent"
s21	"75 percent of patient"	rdfs:member	"patient"
s21	"patient in cortisone spar"	rdfs:member	"patient"
s21	"patient in cortisone spar"	rdfs:member	"cortisone spar"
s21	"compare with rituximab treatment"	rdfs:member	"compare"
s21	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s20.1	"cortisone sparing compared with rituximab treatment as a secondline"
s20.1	"cortisone sparing compared with rituximab treatment as a secondline"	rdf:subject	"cortisone"
s20.1	"cortisone sparing compared with rituximab treatment as a secondline"	rdf:predicate	"spar"
s20.1	"cortisone sparing compared with rituximab treatment as a secondline"	local:AM-ADV	"compare with rituximab treatment a a secondline"
s20.1	"compare with rituximab treatment a a secondline"	rdfs:member	"secondline"
s20.1	"compare with rituximab treatment a a secondline"	rdfs:member	"compare"
s20.1	"compare with rituximab treatment a a secondline"	rdfs:member	"rituximab treatment"
s20.1	"rituximab treatment"	rdfs:member	"rituximab"
s20.1	"rituximab treatment"	rdfs:subClassOf	"treatment"
s20.1	"compare with rituximab treatment"	rdfs:member	"compare"
s20.1	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s20	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as a secondline"
s20	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as a secondline"	rdf:subject	"use of rituximab a a firstline immunosuppressant"
s20	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"use"
s20	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"rituximab"
s20	"use of rituximab a a firstline immunosuppressant"	rdfs:member	"firstline immunosuppressant"
s20	"firstline immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s20	"firstline immunosuppressant"	rdfs:member	"firstline"
s20	"use of rituximab"	rdfs:member	"use"
s20	"use of rituximab"	rdfs:member	"rituximab"
s20	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as a secondline"	rdf:predicate	"show"
s20	"the use of rituximab as a firstline immunosuppressant showed a better efficacy with a discontinuation of immunosuppressants in 75 percent of results in cortisone sparing compared with rituximab treatment as a secondline"	rdf:object	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"secondline"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"percent"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"rituximab treatment"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"cortisone spar compare"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"better efficacy"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"result"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"discontinuation"
s20	"better efficacy with a discontinuation of immunosuppressant in 75 percent of result in cortisone spar compare with rituximab treatment a a secondline"	rdfs:member	"immunosuppressant"
s20	"cortisone spar"	rdfs:subClassOf	"spar"
s20	"spar compare"	rdfs:subClassOf	"compare"
s20	"rituximab treatment"	rdfs:member	"rituximab"
s20	"rituximab treatment"	rdfs:subClassOf	"treatment"
s20	"cortisone spar compare"	rdfs:member	"cortisone spar"
s20	"better efficacy"	rdfs:subClassOf	"efficacy"
s20	"better efficacy"	rdfs:member	"better"
s20	"spar compare"	rdfs:member	"spar"
s20	"cortisone spar"	rdfs:member	"cortisone"
s20	"cortisone spar compare"	rdfs:subClassOf	"compare"
s20	"75 percent"	rdfs:subClassOf	"percent"
s20	"better efficacy with discontinuation"	rdfs:member	"better efficacy"
s20	"better efficacy with discontinuation"	rdfs:member	"discontinuation"
s20	"discontinuation of immunosuppressant"	rdfs:member	"discontinuation"
s20	"discontinuation of immunosuppressant"	rdfs:member	"immunosuppressant"
s20	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"discontinuation of immunosuppressant"
s20	"discontinuation of immunosuppressant in 75 percent"	rdfs:member	"75 percent"
s20	"75 percent of result"	rdfs:member	"75 percent"
s20	"75 percent of result"	rdfs:member	"result"
s20	"result in cortisone spar"	rdfs:member	"result"
s20	"result in cortisone spar"	rdfs:member	"cortisone spar"
s20	"compare with rituximab treatment"	rdfs:member	"compare"
s20	"compare with rituximab treatment"	rdfs:member	"rituximab treatment"
s19	"patients treated with rituximab"
s19	"patients treated with rituximab"	rdf:subject	"patient"
s19	"patients treated with rituximab"	rdf:predicate	"treat"
s19	"patients treated with rituximab"	rdf:object	"rituximab"
s18	"patients had a better outcome than patients"
s18	"patients had a better outcome than patients"	rdf:subject	"patient"
s18	"patients had a better outcome than patients"	rdf:predicate	"have"
s18	"patients had a better outcome than patients"	rdf:object	"better outcome than patient"
s18	"better outcome than patient"	rdfs:member	"better outcome"
s18	"better outcome than patient"	rdfs:member	"patient"
s18	"better outcome"	rdfs:subClassOf	"outcome"
s18	"better outcome"	rdfs:member	"better"
s18	"better outcome than patient"	rdfs:member	"better outcome"
s18	"better outcome than patient"	rdfs:member	"patient"
s17	"patients treated with conventional immunosuppressants"
s17	"patients treated with conventional immunosuppressants"	rdf:subject	"patient"
s17	"patients treated with conventional immunosuppressants"	rdf:predicate	"treat"
s17	"patients treated with conventional immunosuppressants"	rdf:object	"conventional immunosuppressant"
s17	"conventional immunosuppressant"	rdfs:subClassOf	"immunosuppressant"
s17	"conventional immunosuppressant"	rdfs:member	"conventional"
s16	"outcome defined as the therapeutic status of patients at the last visit"
s16	"outcome defined as the therapeutic status of patients at the last visit"	rdf:subject	"outcome"
s16	"outcome defined as the therapeutic status of patients at the last visit"	rdf:predicate	"define"
s16	"outcome defined as the therapeutic status of patients at the last visit"	rdf:object	"therapeutic status of patient"
s16	"therapeutic status of patient"	rdfs:member	"patient"
s16	"therapeutic status of patient"	rdfs:member	"therapeutic status"
s16	"therapeutic status"	rdfs:member	"therapeutic"
s16	"therapeutic status"	rdfs:subClassOf	"status"
s16	"therapeutic status of patient"	rdfs:member	"therapeutic status"
s16	"therapeutic status of patient"	rdfs:member	"patient"
s16	"outcome defined as the therapeutic status of patients at the last visit"	local:AM-TMP	"last visit"
s16	"last visit"	rdfs:subClassOf	"visit"
s16	"last visit"	rdfs:member	"last"
s15	"outcome defined stable without immunosuppressants stable with immunosuppressants"
s15	"outcome defined stable without immunosuppressants stable with immunosuppressants"	rdf:subject	"outcome"
s15	"outcome defined stable without immunosuppressants stable with immunosuppressants"	rdf:predicate	"define"
s15	"outcome defined stable without immunosuppressants stable with immunosuppressants"	local:AM-MNR	"stable without immunosuppressant stable with immunosuppressant"
s15	"immunosuppressant stable"	rdfs:subClassOf	"stable"
s15	"stable without immunosuppressant stable"	rdfs:member	"stable"
s15	"stable without immunosuppressant stable"	rdfs:member	"immunosuppressant stable"
s15	"immunosuppressant stable with immunosuppressant"	rdfs:member	"immunosuppressant stable"
s15	"immunosuppressant stable with immunosuppressant"	rdfs:member	"immunosuppressant"
s14	"outcome defined as the clinical status of patients at the last visit"
s14	"outcome defined as the clinical status of patients at the last visit"	rdf:subject	"outcome"
s14	"outcome defined as the clinical status of patients at the last visit"	rdf:predicate	"define"
s14	"outcome defined as the clinical status of patients at the last visit"	rdf:object	"clinical status of patient"
s14	"clinical status of patient"	rdfs:member	"patient"
s14	"clinical status of patient"	rdfs:member	"clinical status"
s14	"clinical status"	rdfs:subClassOf	"status"
s14	"clinical status"	rdfs:member	"clinical"
s14	"clinical status of patient"	rdfs:member	"clinical status"
s14	"clinical status of patient"	rdfs:member	"patient"
s14	"outcome defined as the clinical status of patients at the last visit"	local:AM-TMP	"last visit"
s14	"last visit"	rdfs:subClassOf	"visit"
s14	"last visit"	rdfs:member	"last"
s12.1	"to evaluate the efficacy of rituximab we studied the clinical course of patients on immunosuppressive therapy"
s12.1	"to evaluate the efficacy of rituximab we studied the clinical course of patients on immunosuppressive therapy"	rdf:subject	"we"
s12.1	"to evaluate the efficacy of rituximab we studied the clinical course of patients on immunosuppressive therapy"	rdf:predicate	"study"
s12.1	"to evaluate the efficacy of rituximab we studied the clinical course of patients on immunosuppressive therapy"	rdf:object	"clinical course of patient on immunosuppressive therapy"
s12.1	"clinical course of patient on immunosuppressive therapy"	rdfs:member	"immunosuppressive therapy"
s12.1	"clinical course of patient on immunosuppressive therapy"	rdfs:member	"clinical course"
s12.1	"clinical course of patient on immunosuppressive therapy"	rdfs:member	"patient"
s12.1	"clinical course"	rdfs:subClassOf	"course"
s12.1	"immunosuppressive therapy"	rdfs:subClassOf	"therapy"
s12.1	"clinical course"	rdfs:member	"clinical"
s12.1	"immunosuppressive therapy"	rdfs:member	"immunosuppressive"
s12.1	"clinical course of patient"	rdfs:member	"clinical course"
s12.1	"clinical course of patient"	rdfs:member	"patient"
s12.1	"patient on immunosuppressive therapy"	rdfs:member	"patient"
s12.1	"patient on immunosuppressive therapy"	rdfs:member	"immunosuppressive therapy"
s12.1	"to evaluate the efficacy of rituximab we studied the clinical course of patients on immunosuppressive therapy"	local:AM-PNC	"evaluate the efficacy of rituximab"
s12.1	"evaluate the efficacy of rituximab"	rdfs:member	"rituximab"
s12.1	"evaluate the efficacy of rituximab"	rdfs:member	"efficacy"
s12.1	"efficacy of rituximab"	rdfs:member	"efficacy"
s12.1	"efficacy of rituximab"	rdfs:member	"rituximab"
s12	"evaluate the efficacy of rituximab we"
s12	"evaluate the efficacy of rituximab we"	rdf:subject	"we"
s12	"evaluate the efficacy of rituximab we"	rdf:predicate	"evaluate"
s12	"evaluate the efficacy of rituximab we"	rdf:object	"efficacy of rituximab"
s12	"efficacy of rituximab"	rdfs:member	"rituximab"
s12	"efficacy of rituximab"	rdfs:member	"efficacy"
s12	"efficacy of rituximab"	rdfs:member	"efficacy"
s12	"efficacy of rituximab"	rdfs:member	"rituximab"
s11	"different lines of immunosuppressive treatment"
s11	"different lines of immunosuppressive treatment"	rdf:subject	"different line of immunosuppressive treatment"
s11	"different line of immunosuppressive treatment"	rdfs:member	"different line"
s11	"different line of immunosuppressive treatment"	rdfs:member	"immunosuppressive treatment"
s11	"different line"	rdfs:subClassOf	"line"
s11	"immunosuppressive treatment"	rdfs:subClassOf	"treatment"
s11	"immunosuppressive treatment"	rdfs:member	"immunosuppressive"
s11	"different line"	rdfs:member	"different"
s11	"different line of immunosuppressive treatment"	rdfs:member	"different line"
s11	"different line of immunosuppressive treatment"	rdfs:member	"immunosuppressive treatment"
s11	"different lines of immunosuppressive treatment"	rdf:predicate	"collect"
s10	"clinical course of the patients"
s10	"clinical course of the patients"	rdf:subject	"clinical course of the patient"
s10	"clinical course of the patient"	rdfs:member	"clinical course"
s10	"clinical course of the patient"	rdfs:member	"patient"
s10	"clinical course"	rdfs:subClassOf	"course"
s10	"clinical course"	rdfs:member	"clinical"
s10	"clinical course of patient"	rdfs:member	"clinical course"
s10	"clinical course of patient"	rdfs:member	"patient"
s10	"clinical course of the patients"	rdf:predicate	"collect"
s9	"the type of myasthenia"
s9	"the type of myasthenia"	rdf:subject	"type of myasthenia"
s9	"type of myasthenia"	rdfs:member	"myasthenia"
s9	"type of myasthenia"	rdfs:member	"type"
s9	"type of myasthenia"	rdfs:member	"type"
s9	"type of myasthenia"	rdfs:member	"myasthenia"
s9	"the type of myasthenia"	rdf:predicate	"collect"
s8.1	"a retrospective multicenter study april 30 2020"
s8.1	"a retrospective multicenter study april 30 2020"	rdf:subject	"retrospective multicenter study"
s8.1	"retrospective multicenter"	rdfs:member	"retrospective"
s8.1	"multicenter study"	rdfs:member	"multicenter"
s8.1	"retrospective multicenter study"	rdfs:member	"retrospective multicenter"
s8.1	"retrospective multicenter study"	rdfs:subClassOf	"study"
s8.1	"retrospective multicenter"	rdfs:subClassOf	"multicenter"
s8.1	"multicenter study"	rdfs:subClassOf	"study"
s8.1	"retrospective multicenter study"	rdfs:subClassOf	"multicenter study"
s8.1	"a retrospective multicenter study april 30 2020"	rdf:predicate	"april"
s8.1	"a retrospective multicenter study april 30 2020"	rdf:object	"30 2020"
s8.1	"30 2020"	rdfs:subClassOf	"2020"
s8	"we conducted a retrospective multicenter study from january 1 2009 to april 30 2020"
s8	"we conducted a retrospective multicenter study from january 1 2009 to april 30 2020"	rdf:subject	"we"
s8	"we conducted a retrospective multicenter study from january 1 2009 to april 30 2020"	rdf:predicate	"conduct"
s8	"we conducted a retrospective multicenter study from january 1 2009 to april 30 2020"	rdf:object	"retrospective multicenter study"
s8	"retrospective multicenter"	rdfs:member	"retrospective"
s8	"multicenter study"	rdfs:member	"multicenter"
s8	"retrospective multicenter study"	rdfs:member	"retrospective multicenter"
s8	"retrospective multicenter study"	rdfs:subClassOf	"study"
s8	"retrospective multicenter"	rdfs:subClassOf	"multicenter"
s8	"multicenter study"	rdfs:subClassOf	"study"
s8	"retrospective multicenter study"	rdfs:subClassOf	"multicenter study"
s8	"we conducted a retrospective multicenter study from january 1 2009 to april 30 2020"	local:AM-TMP	"january 1 2009 to april 30 2020"
s8	"2020 january"	rdfs:subClassOf	"january"
s8	"30 april"	rdfs:subClassOf	"april"
s8	"2009 2020 january"	rdfs:subClassOf	"2020 january"
s8	"1 2009"	rdfs:subClassOf	"2009"
s8	"2009 2020 january to 30 april"	rdfs:member	"2009 2020 january"
s8	"2009 2020 january to 30 april"	rdfs:member	"30 april"
s5	"we conducted a retrospective multicenter study from january 1 2009 to"
s5	"we conducted a retrospective multicenter study from january 1 2009 to"	rdf:subject	"we"
s5	"we conducted a retrospective multicenter study from january 1 2009 to"	rdf:predicate	"conduct"
s5	"we conducted a retrospective multicenter study from january 1 2009 to"	rdf:object	"retrospective multicenter study"
s5	"retrospective multicenter"	rdfs:member	"retrospective"
s5	"multicenter study"	rdfs:member	"multicenter"
s5	"retrospective multicenter study"	rdfs:member	"retrospective multicenter"
s5	"retrospective multicenter study"	rdfs:subClassOf	"study"
s5	"retrospective multicenter"	rdfs:subClassOf	"multicenter"
s5	"multicenter study"	rdfs:subClassOf	"study"
s5	"retrospective multicenter study"	rdfs:subClassOf	"multicenter study"
s5	"we conducted a retrospective multicenter study from january 1 2009 to"	local:AM-TMP	"january 1 2009 to"
s5	"2009 january"	rdfs:subClassOf	"january"
s5	"1 2009"	rdfs:subClassOf	"2009"
s4.1	"propose a new place in the therapeutic strategy of juvenile myasthenia gravis"
s4.1	"propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:subject	"new place in the therapeutic strategy of juvenile myasthenia gravis"
s4.1	"new place in the therapeutic strategy of juvenile myasthenia gravis"	rdfs:member	"juvenile myasthenia gravis"
s4.1	"new place in the therapeutic strategy of juvenile myasthenia gravis"	rdfs:member	"therapeutic strategy"
s4.1	"new place in the therapeutic strategy of juvenile myasthenia gravis"	rdfs:member	"new place"
s4.1	"myasthenia gravis"	rdfs:member	"myasthenia"
s4.1	"juvenile myasthenia"	rdfs:subClassOf	"myasthenia"
s4.1	"therapeutic strategy"	rdfs:subClassOf	"strategy"
s4.1	"therapeutic strategy"	rdfs:member	"therapeutic"
s4.1	"new place"	rdfs:member	"new"
s4.1	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s4.1	"juvenile myasthenia gravis"	rdfs:member	"juvenile myasthenia"
s4.1	"juvenile myasthenia"	rdfs:member	"juvenile"
s4.1	"juvenile myasthenia gravis"	rdfs:subClassOf	"gravis"
s4.1	"new place"	rdfs:subClassOf	"place"
s4.1	"new place in therapeutic strategy"	rdfs:member	"new place"
s4.1	"new place in therapeutic strategy"	rdfs:member	"therapeutic strategy"
s4.1	"therapeutic strategy of juvenile myasthenia"	rdfs:member	"therapeutic strategy"
s4.1	"therapeutic strategy of juvenile myasthenia"	rdfs:member	"juvenile myasthenia"
s4.1	"propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:predicate	"propose"
s4	"describe the use of rituximab to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"
s4	"describe the use of rituximab to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:subject	"use of rituximab"
s4	"use of rituximab"	rdfs:member	"use"
s4	"use of rituximab"	rdfs:member	"rituximab"
s4	"use of rituximab"	rdfs:member	"use"
s4	"use of rituximab"	rdfs:member	"rituximab"
s4	"describe the use of rituximab to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:predicate	"describe"
s4	"describe the use of rituximab to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	local:AM-PNC	"propose a new place in the therapeutic strategy of juvenile myasthenia gravis"
s3.1	"the french neuromuscular reference network propose a new place in the therapeutic strategy of juvenile myasthenia gravis"
s3.1	"the french neuromuscular reference network propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:subject	"french neuromuscular reference network"
s3.1	"french neuromuscular reference"	rdfs:subClassOf	"reference"
s3.1	"french neuromuscular reference network"	rdfs:member	"french neuromuscular reference"
s3.1	"neuromuscular reference"	rdfs:member	"neuromuscular"
s3.1	"neuromuscular reference"	rdfs:subClassOf	"reference"
s3.1	"reference network"	rdfs:subClassOf	"network"
s3.1	"french neuromuscular"	rdfs:subClassOf	"neuromuscular"
s3.1	"french neuromuscular reference"	rdfs:member	"french neuromuscular"
s3.1	"reference network"	rdfs:member	"reference"
s3.1	"french neuromuscular reference network"	rdfs:subClassOf	"network"
s3.1	"neuromuscular reference network"	rdfs:member	"neuromuscular reference"
s3.1	"neuromuscular reference network"	rdfs:subClassOf	"network"
s3.1	"french neuromuscular"	rdfs:member	"french"
s3.1	"neuromuscular reference network"	rdfs:subClassOf	"reference network"
s3.1	"french neuromuscular reference network"	rdfs:subClassOf	"neuromuscular reference network"
s3.1	"the french neuromuscular reference network propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:predicate	"propose"
s3.1	"the french neuromuscular reference network propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:object	"new place in the therapeutic strategy of juvenile myasthenia gravis"
s3.1	"new place in the therapeutic strategy of juvenile myasthenia gravis"	rdfs:member	"juvenile myasthenia gravis"
s3.1	"new place in the therapeutic strategy of juvenile myasthenia gravis"	rdfs:member	"therapeutic strategy"
s3.1	"new place in the therapeutic strategy of juvenile myasthenia gravis"	rdfs:member	"new place"
s3.1	"myasthenia gravis"	rdfs:member	"myasthenia"
s3.1	"juvenile myasthenia"	rdfs:subClassOf	"myasthenia"
s3.1	"therapeutic strategy"	rdfs:subClassOf	"strategy"
s3.1	"therapeutic strategy"	rdfs:member	"therapeutic"
s3.1	"new place"	rdfs:member	"new"
s3.1	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s3.1	"juvenile myasthenia gravis"	rdfs:member	"juvenile myasthenia"
s3.1	"juvenile myasthenia"	rdfs:member	"juvenile"
s3.1	"juvenile myasthenia gravis"	rdfs:subClassOf	"gravis"
s3.1	"new place"	rdfs:subClassOf	"place"
s3.1	"new place in therapeutic strategy"	rdfs:member	"new place"
s3.1	"new place in therapeutic strategy"	rdfs:member	"therapeutic strategy"
s3.1	"therapeutic strategy of juvenile myasthenia"	rdfs:member	"therapeutic strategy"
s3.1	"therapeutic strategy of juvenile myasthenia"	rdfs:member	"juvenile myasthenia"
s3	"describe this study efficacy and safety in 8 main pediatric centers of the french neuromuscular reference network to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"
s3	"describe this study efficacy and safety in 8 main pediatric centers of the french neuromuscular reference network to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:subject	"study efficacy and safety in 8 main pediatric center of the french neuromuscular reference network"
s3	"study efficacy and safety in 8 main pediatric center of the french neuromuscular reference network"	rdfs:member	"safety"
s3	"study efficacy and safety in 8 main pediatric center of the french neuromuscular reference network"	rdfs:member	"french neuromuscular reference network"
s3	"study efficacy and safety in 8 main pediatric center of the french neuromuscular reference network"	rdfs:member	"study efficacy"
s3	"study efficacy and safety in 8 main pediatric center of the french neuromuscular reference network"	rdfs:member	"main pediatric center"
s3	"french neuromuscular reference"	rdfs:subClassOf	"reference"
s3	"main pediatric center"	rdfs:subClassOf	"center"
s3	"french neuromuscular reference network"	rdfs:member	"french neuromuscular reference"
s3	"pediatric center"	rdfs:subClassOf	"center"
s3	"neuromuscular reference"	rdfs:subClassOf	"reference"
s3	"main pediatric center"	rdfs:member	"main pediatric"
s3	"main pediatric"	rdfs:subClassOf	"pediatric"
s3	"reference network"	rdfs:member	"reference"
s3	"neuromuscular reference network"	rdfs:member	"neuromuscular reference"
s3	"reference network"	rdfs:subClassOf	"network"
s3	"pediatric center"	rdfs:member	"pediatric"
s3	"neuromuscular reference network"	rdfs:subClassOf	"network"
s3	"french neuromuscular"	rdfs:member	"french"
s3	"study efficacy"	rdfs:member	"study"
s3	"french neuromuscular reference network"	rdfs:subClassOf	"network"
s3	"study efficacy"	rdfs:subClassOf	"efficacy"
s3	"neuromuscular reference"	rdfs:member	"neuromuscular"
s3	"main pediatric"	rdfs:member	"main"
s3	"french neuromuscular"	rdfs:subClassOf	"neuromuscular"
s3	"french neuromuscular reference"	rdfs:member	"french neuromuscular"
s3	"neuromuscular reference network"	rdfs:subClassOf	"reference network"
s3	"french neuromuscular reference network"	rdfs:subClassOf	"neuromuscular reference network"
s3	"main pediatric center"	rdfs:subClassOf	"pediatric center"
s3	"8 main pediatric center"	rdfs:subClassOf	"main pediatric center"
s3	"study efficacy in 8 main pediatric center"	rdfs:member	"study efficacy"
s3	"study efficacy in 8 main pediatric center"	rdfs:member	"8 main pediatric center"
s3	"8 main pediatric center of french neuromuscular reference network"	rdfs:member	"8 main pediatric center"
s3	"8 main pediatric center of french neuromuscular reference network"	rdfs:member	"french neuromuscular reference network"
s3	"describe this study efficacy and safety in 8 main pediatric centers of the french neuromuscular reference network to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	rdf:predicate	"describe"
s3	"describe this study efficacy and safety in 8 main pediatric centers of the french neuromuscular reference network to propose a new place in the therapeutic strategy of juvenile myasthenia gravis"	local:AM-PNC	"propose a new place in the therapeutic strategy of juvenile myasthenia gravis"
s2	"the place of new immunosuppressive therapies not clearly defined by the last international consensus"
s2	"the place of new immunosuppressive therapies not clearly defined by the last international consensus"	rdf:subject	"last international consensus"
s2	"last international consensus"	rdfs:member	"last international"
s2	"last international consensus"	rdfs:subClassOf	"consensus"
s2	"international consensus"	rdfs:subClassOf	"consensus"
s2	"international consensus"	rdfs:member	"international"
s2	"last international"	rdfs:subClassOf	"international"
s2	"last international"	rdfs:member	"last"
s2	"last international consensus"	rdfs:subClassOf	"international consensus"
s2	"the place of new immunosuppressive therapies not clearly defined by the last international consensus"	rdf:predicate	"not define"
s2	"the place of new immunosuppressive therapies not clearly defined by the last international consensus"	rdf:object	"place of new immunosuppressive therapy"
s2	"place of new immunosuppressive therapy"	rdfs:member	"place"
s2	"place of new immunosuppressive therapy"	rdfs:member	"new immunosuppressive therapy"
s2	"new immunosuppressive therapy"	rdfs:member	"new immunosuppressive"
s2	"new immunosuppressive therapy"	rdfs:subClassOf	"therapy"
s2	"new immunosuppressive"	rdfs:subClassOf	"immunosuppressive"
s2	"immunosuppressive therapy"	rdfs:subClassOf	"therapy"
s2	"new immunosuppressive"	rdfs:member	"new"
s2	"immunosuppressive therapy"	rdfs:member	"immunosuppressive"
s2	"new immunosuppressive therapy"	rdfs:subClassOf	"immunosuppressive therapy"
s2	"place of new immunosuppressive therapy"	rdfs:member	"place"
s2	"place of new immunosuppressive therapy"	rdfs:member	"new immunosuppressive therapy"
s2	"the place of new immunosuppressive therapies not clearly defined by the last international consensus"	local:AM-MNR	"clearly"
s1	"the last international consensus held in march 2019 due to the lack of clinical trials"
s1	"the last international consensus held in march 2019 due to the lack of clinical trials"	rdf:subject	"last international consensus"
s1	"last international consensus"	rdfs:member	"last international"
s1	"last international consensus"	rdfs:subClassOf	"consensus"
s1	"international consensus"	rdfs:subClassOf	"consensus"
s1	"international consensus"	rdfs:member	"international"
s1	"last international"	rdfs:subClassOf	"international"
s1	"last international"	rdfs:member	"last"
s1	"last international consensus"	rdfs:subClassOf	"international consensus"
s1	"the last international consensus held in march 2019 due to the lack of clinical trials"	rdf:predicate	"hold"
s1	"the last international consensus held in march 2019 due to the lack of clinical trials"	local:AM-TMP	"march 2019 due to the lack of clinical trial"
s1	"march 2019 due to the lack of clinical trial"	rdfs:member	"lack"
s1	"march 2019 due to the lack of clinical trial"	rdfs:member	"clinical trial"
s1	"march 2019 due to the lack of clinical trial"	rdfs:member	"march"
s1	"clinical trial"	rdfs:subClassOf	"trial"
s1	"clinical trial"	rdfs:member	"clinical"
s1	"2019 due_to lack"	rdfs:member	"2019"
s1	"2019 due_to lack"	rdfs:member	"lack"
s1	"lack of clinical trial"	rdfs:member	"lack"
s1	"lack of clinical trial"	rdfs:member	"clinical trial"
